Marta Román
Oslo University Hospital
47 Papers
75 Citations
Marta Román is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 11, co-authored 36 publications.
Chat about Author
Papers
Comorbidities and Mortality in Patients With COVID-19 Aged 60 Years and Older in a University Hospital in Spain.
Margarita Posso,Mercè Comas,Marta Román,Laia Domingo,Javier Louro,Cristina González,Maria Sala,Albert Anglès,Isabel Cirera,Francesc Cots,Víctor-Manuel Frías,Joaquim Gea,Robert Güerri-Fernández,Joan R. Masclans,Xavier Nogués,Olga Vázquez,Judith Villar-García,Juan Pablo Horcajada,Julio Pascual,Xavier Castells +19 more
76
Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.
Xavier Castells,Laia Domingo,Josep M. Corominas,Isabel Torá-Rocamora,María Jesús Quintana,Marisa Baré,Carmen Vidal,Carmen Natal,Mar Sánchez,Francina Saladié,Joana Ferrer,Mar Vernet,Sonia Servitja,Ana Rodríguez-Arana,Marta Román,Josep A. Espinàs,Maria Sala +16 more
TL;DR: An increased risk of breast cancer was observed among screening participants with proliferative or nonproliferative benign breast disease, regardless of a family history of Breast cancer.
Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features.
Xavier Castells,Isabel Torá-Rocamora,Margarita Posso,Marta Román,María Vernet-Tomas,Ana Rodríguez-Arana,Laia Domingo,Carmen Vidal,Marisa Baré,Joana Ferrer,María Jesús Quintana,Mar Sánchez,Carmen Natal,Josep A. Espinàs,Francina Saladié,Maria Sala +15 more
TL;DR: Women who had more than one examination with false-positive findings and in whom the mammographic features changed over time had a highly increased risk of breast cancer.
41
Mode of detection: an independent prognostic factor for women with breast cancer.
TL;DR: Investigating breast cancer survival and risk of breast cancer death by detection mode (screen-detected, interval, and detected outside the screening programme), adjusting for prognostic and predictive tumour characteristics found detection mode is an independent prognostic factor for women diagnosed with breast cancer.
35
Postmenopausal Hormone Therapy and Breast Cancer Prognostic Characteristics: A Linkage between Nationwide Registries
Marta Román,Sidsel Graff-Iversen,Sidsel Graff-Iversen,Elisabete Weiderpass,Siri Vangen,Solveig Sakshaug,Solveig Hofvind,Giske Ursin +7 more
TL;DR: The hormone therapy preparations most commonly used in the Nordic countries are associated with both breast cancers with good and less favorable prognosis characteristics, and use of estradiol–NETA preparations also increases the risk of breast cancer with less favorable characteristics.